151 related articles for article (PubMed ID: 31692929)
1. Nucleotide variations of
Bukovac A; Kafka A; Hrašćan R; Vladušić T; Pećina-Šlaus N
Mol Clin Oncol; 2019 Dec; 11(6):563-572. PubMed ID: 31692929
[TBL] [Abstract][Full Text] [Related]
2. Identification of Genetic Variants in Exon 4 of TP53 in Lung Carcinoma and in Silico Prediction of Their Significance.
Prasad R; Sharma K; Bhutani K; Prasad S; Manhas S; Kishan J
Indian J Clin Biochem; 2024 Apr; 39(2):276-282. PubMed ID: 38577139
[TBL] [Abstract][Full Text] [Related]
3. TP53 mutations in human meningiomas.
Verheijen FM; Sprong M; Kloosterman JM; Blaauw G; Thijssen JH; Blankenstein MA
Int J Biol Markers; 2002; 17(1):42-8. PubMed ID: 11936585
[TBL] [Abstract][Full Text] [Related]
4. Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples.
Wang JL; Zhang ZJ; Hartman M; Smits A; Westermark B; Muhr C; Nistér M
Int J Cancer; 1995 Aug; 64(4):223-8. PubMed ID: 7657383
[TBL] [Abstract][Full Text] [Related]
5. Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression.
Pećina-Šlaus N; Kafka A; Vladušić T; Tomas D; Logara M; Skoko J; Hrašćan R
Int J Exp Pathol; 2016 Apr; 97(2):159-69. PubMed ID: 27292269
[TBL] [Abstract][Full Text] [Related]
6. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
[TBL] [Abstract][Full Text] [Related]
7. p53 gene mutations in SKH-1 mouse tumors differentially induced by UVB and combined subcarcinogenic benzo[a]pyrene and UVA.
Wang Y; Zhou X; Weinstein E; Maryles B; Zhang Y; Moore J; Gao D; Atencio DP; Rosenstein BS; Lebwohl M; Chen HD; Xiao T; Wei H
Photochem Photobiol; 2008; 84(2):444-9. PubMed ID: 18248503
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of TP53 mutations in Rwandan patients with gastric cancer.
Nzitakera A; Surwumwe JB; Ndoricyimpaye EL; Uwamungu S; Uwamariya D; Manirakiza F; Ndayisaba MC; Ntakirutimana G; Seminega B; Dusabejambo V; Rutaganda E; Kamali P; Ngabonziza F; Ishikawa R; Rugwizangoga B; Iwashita Y; Yamada H; Yoshimura K; Sugimura H; Shinmura K
Genes Environ; 2024 Mar; 46(1):8. PubMed ID: 38459566
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis.
Kuczyk MA; Serth J; Bokemeyer C; Jonassen J; Machtens S; Werner M; Jonas U
Cancer; 1996 Nov; 78(9):1958-66. PubMed ID: 8909317
[TBL] [Abstract][Full Text] [Related]
10. TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.
Faria MH; Neves Filho EH; Alves MK; Burbano RM; de Moraes Filho MO; Rabenhorst SH
APMIS; 2012 Nov; 120(11):882-9. PubMed ID: 23009112
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of TP53 mutations in bladder carcinoma.
Williamson MP; Elder PA; Knowles MA
Genes Chromosomes Cancer; 1994 Feb; 9(2):108-18. PubMed ID: 7513540
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors.
Pütz A; Hartmann AA; Fontes PR; Alexandre CO; Silveira DA; Klug SJ; Rabes HM
Int J Cancer; 2002 Mar; 98(1):99-105. PubMed ID: 11857392
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent copy number variations of TP53 tumour suppressor gene associated with altered phosphorylation status of p53 protein in sporadic schwannomas.
Chen H; Huang H; Zhao J; Wang Z; Chang M; Xue L; Zhu W; Chai Y; Li G; Wang Z; Wu H
J Neurooncol; 2019 Jul; 143(3):369-379. PubMed ID: 31049827
[TBL] [Abstract][Full Text] [Related]
14. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.
Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K
Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
16. TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
Munch-Petersen HD; Asmar F; Dimopoulos K; Areškevičiūtė A; Brown P; Girkov MS; Pedersen A; Sjö LD; Heegaard S; Broholm H; Kristensen LS; Ralfkiaer E; Grønbæk K
Acta Neuropathol Commun; 2016 Apr; 4():40. PubMed ID: 27101868
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review.
Tornesello ML; Buonaguro L; Buonaguro FM
Gynecol Oncol; 2013 Mar; 128(3):442-8. PubMed ID: 23168175
[TBL] [Abstract][Full Text] [Related]
18. Different mutation profiles associated to P53 accumulation in colorectal cancer.
López I; P Oliveira L; Tucci P; Alvarez-Valín F; A Coudry R; Marín M
Gene; 2012 May; 499(1):81-7. PubMed ID: 22373952
[TBL] [Abstract][Full Text] [Related]
19. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
Fathi Z; Mousavi SAJ; Roudi R; Ghazi F
PLoS One; 2018; 13(7):e0200633. PubMed ID: 30048458
[TBL] [Abstract][Full Text] [Related]
20. TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia.
Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martіna ZV
Exp Oncol; 2014 Dec; 36(4):258-61. PubMed ID: 25537220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
